Risk	risk	O	O	O	O
of	of	O	O	O	O
nephropathy	nephropathy	O	DISEASE	OTHERS	I
after	after	O	O	O	O
consumption	consumption	O	O	O	O
of	of	O	O	O	O
nonionic	nonionic	O	O	O	O
contrast	contrast	CHEMICALS	O	OTHERS	I
media	media	CHEMICALS	O	OTHERS	I
by	by	O	O	O	O
children	children	O	O	O	O
undergoing	undergoing	O	O	O	O
cardiac	cardiac	O	O	O	O
angiography	angiography	O	O	O	O
:	:	O	O	O	O
a	a	O	O	O	O
prospective	prospective	O	O	O	O
study	study	O	O	O	O
.	.	O	O	O	O

Despite	despite	O	O	O	O
increasing	increasing	O	O	O	O
reports	reports	O	O	O	O
on	on	O	O	O	O
nonionic	nonionic	O	O	O	O
contrast	contrast	O	O	OTHERS	I
media-induced	media-induced	O	O	O	O
nephropathy	nephropathy	O	DISEASE	OTHERS	I
(	(	O	O	O	O
CIN	cin	O	O	OTHERS	I
)	)	O	O	O	O
in	in	O	O	O	O
hospitalized	hospitalized	O	O	O	O
adult	adult	O	O	O	O
patients	patients	O	O	O	O
during	during	O	O	O	O
cardiac	cardiac	O	O	O	O
procedures	procedures	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
studies	studies	O	O	O	O
in	in	O	O	O	O
pediatrics	pediatrics	O	O	O	O
are	are	O	O	O	O
limited	limited	O	O	O	O
,	,	O	O	O	O
with	with	O	O	O	O
even	even	O	O	O	O
less	less	O	O	O	O
focus	focus	O	O	O	O
on	on	O	O	O	O
possible	possible	O	O	O	O
predisposing	predisposing	O	O	O	O
factors	factors	O	O	O	O
and	and	O	O	O	O
preventive	preventive	O	O	O	O
measures	measures	O	O	O	O
for	for	O	O	O	O
patients	patients	O	O	O	O
undergoing	undergoing	O	O	O	O
cardiac	cardiac	O	O	O	O
angiography	angiography	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
prospective	prospective	O	O	O	O
study	study	O	O	O	O
determined	determined	O	O	O	O
the	the	O	O	O	O
incidence	incidence	O	O	O	O
of	of	O	O	O	O
CIN	cin	O	O	OTHERS	I
for	for	O	O	O	O
two	two	O	O	O	O
nonionic	nonionic	O	O	O	O
contrast	contrast	CHEMICALS	O	OTHERS	I
media	media	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
CM	cm	O	DISEASE	OTHERS	I
)	)	O	O	O	O
,	,	O	O	O	O
iopromide	iopromide	O	O	OTHERS	I
and	and	O	O	O	O
iohexol	iohexol	O	O	OTHERS	I
,	,	O	O	O	O
among	among	O	O	O	O
80	80	O	O	O	O
patients	patients	O	O	O	O
younger	younger	O	O	O	O
than	than	O	O	O	O
18	18	O	O	O	O
years	years	O	O	O	O
and	and	O	O	O	O
compared	compared	O	O	O	O
the	the	O	O	O	O
rates	rates	O	O	O	O
for	for	O	O	O	O
this	this	O	O	O	O
complication	complication	O	O	O	O
in	in	O	O	O	O
relation	relation	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
type	type	O	O	O	O
and	and	O	O	O	O
dosage	dosage	O	O	O	O
of	of	O	O	O	O
CM	cm	O	DISEASE	OTHERS	I
and	and	O	O	O	O
the	the	O	O	O	O
presence	presence	O	O	O	O
of	of	O	O	O	O
cyanosis	cyanosis	O	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
80	80	O	O	O	O
patients	patients	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
study	study	O	O	O	O
consecutively	consecutively	O	O	O	O
received	received	O	O	O	O
either	either	O	O	O	O
iopromide	iopromide	O	O	OTHERS	I
(	(	O	O	O	O
group	group	O	O	O	O
A	a	O	O	O	O
,	,	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
40	40	O	O	O	O
)	)	O	O	O	O
or	or	O	O	O	O
iohexol	iohexol	O	O	OTHERS	I
(	(	O	O	O	O
group	group	O	O	O	O
B	b	O	O	O	O
,	,	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
40	40	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Serum	serum	O	O	O	O
sodium	sodium	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
Na	na	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
,	,	O	O	O	O
potassium	potassium	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
K	k	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
creatinine	creatinine	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
Cr	cr	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
were	were	O	O	O	O
measured	measured	O	O	O	O
24	24	O	O	O	O
h	h	CHEMICALS	O	OTHERS	I
before	before	O	O	O	O
angiography	angiography	O	O	O	O
as	as	O	O	O	O
baseline	baseline	O	O	O	O
values	values	O	O	O	O
,	,	O	O	O	O
then	then	O	O	O	O
measured	measured	O	O	O	O
again	again	O	O	O	O
at	at	O	O	O	O
12-	12-	O	O	O	O
,	,	O	O	O	O
24-	24-	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
48-h	48-h	O	O	O	O
intervals	intervals	O	O	O	O
after	after	O	O	O	O
CM	cm	O	DISEASE	OTHERS	I
use	use	O	O	O	O
.	.	O	O	O	O

Urine	urine	O	O	O	O
samples	samples	O	O	O	O
for	for	O	O	O	O
Na	na	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
Cr	cr	CHEMICALS	O	OTHERS	I
also	also	O	O	O	O
were	were	O	O	O	O
checked	checked	O	O	O	O
at	at	O	O	O	O
the	the	O	O	O	O
same	same	O	O	O	O
intervals	intervals	O	O	O	O
.	.	O	O	O	O

Risk	risk	O	O	O	O
of	of	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
,	,	O	O	O	O
Injury	injury	O	O	OTHERS	I
to	to	O	O	OTHERS	I
the	the	O	O	OTHERS	I
kidney	kidney	O	O	OTHERS	I
,	,	O	O	O	O
Failure	failure	O	O	OTHERS	I
of	of	O	O	OTHERS	I
kidney	kidney	O	O	OTHERS	I
function	function	O	O	OTHERS	I
,	,	O	O	O	O
Loss	loss	O	O	OTHERS	I
of	of	O	O	OTHERS	I
kidney	kidney	O	O	OTHERS	I
function	function	O	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
End-stage	end-stage	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
damage	damage	O	DISEASE	OTHERS	I
(	(	O	O	O	O
RIFLE	rifle	O	O	O	O
criteria	criteria	O	O	O	O
)	)	O	O	O	O
were	were	O	O	O	O
used	used	O	O	O	O
to	to	O	O	O	O
define	define	O	O	O	O
CIN	cin	O	O	OTHERS	I
and	and	O	O	O	O
its	its	O	O	O	O
incidence	incidence	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
study	study	O	O	O	O
population	population	O	O	O	O
.	.	O	O	O	O

Accordingly	accordingly	O	O	O	O
,	,	O	O	O	O
among	among	O	O	O	O
the	the	O	O	O	O
15	15	O	O	O	O
CIN	cin	O	O	OTHERS	I
patients	patients	O	O	O	O
(	(	O	O	O	O
18.75	18.75	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
7.5	7.5	O	O	O	O
%	%	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
patients	patients	O	O	O	O
in	in	O	O	O	O
group	group	O	O	O	O
A	a	O	O	O	O
had	had	O	O	O	O
increased	increased	O	O	O	O
risk	risk	O	O	O	O
and	and	O	O	O	O
3.75	3.75	O	O	O	O
%	%	O	O	O	O
had	had	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
injury	injury	O	DISEASE	OTHERS	I
,	,	O	O	O	O
whereas	whereas	O	O	O	O
5	5	O	O	O	O
%	%	O	O	O	O
of	of	O	O	O	O
group	group	O	O	O	O
B	b	O	O	O	O
had	had	O	O	O	O
increased	increased	O	O	O	O
risk	risk	O	O	O	O
and	and	O	O	O	O
2.5	2.5	O	O	O	O
%	%	O	O	O	O
had	had	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
injury	injury	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Whereas	whereas	O	O	O	O
33.3	33.3	O	O	O	O
%	%	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
CIN	cin	O	O	OTHERS	I
were	were	O	O	O	O
among	among	O	O	O	O
those	those	O	O	O	O
who	who	O	O	O	O
received	received	O	O	O	O
the	the	O	O	O	O
proper	proper	O	O	O	O
dosage	dosage	O	O	O	O
of	of	O	O	O	O
CM	cm	O	DISEASE	OTHERS	I
,	,	O	O	O	O
the	the	O	O	O	O
percentage	percentage	O	O	O	O
increased	increased	O	O	O	O
to	to	O	O	O	O
66.6	66.6	O	O	O	O
%	%	O	O	O	O
among	among	O	O	O	O
those	those	O	O	O	O
who	who	O	O	O	O
received	received	O	O	O	O
larger	larger	O	O	O	O
doses	doses	O	O	O	O
,	,	O	O	O	O
with	with	O	O	O	O
a	a	O	O	O	O
significant	significant	O	O	O	O
difference	difference	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
incidence	incidence	O	O	O	O
of	of	O	O	O	O
CIN	cin	O	O	OTHERS	I
related	related	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
different	different	O	O	O	O
dosages	dosages	O	O	O	O
of	of	O	O	O	O
CM	cm	O	DISEASE	OTHERS	I
(	(	O	O	O	O
p	p	O	O	OTHERS	I
=	=	O	O	O	O
0.014	0.014	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Among	among	O	O	O	O
the	the	O	O	O	O
15	15	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
CIN	cin	O	O	OTHERS	I
,	,	O	O	O	O
6	6	O	O	O	O
had	had	O	O	O	O
cyanotic	cyanotic	O	O	O	O
congenital	congenital	O	O	OTHERS	I
heart	heart	O	DISEASE	OTHERS	I
diseases	diseases	O	DISEASE	OTHERS	I
,	,	O	O	O	O
but	but	O	O	O	O
the	the	O	O	O	O
incidence	incidence	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
differ	differ	O	O	O	O
significantly	significantly	O	O	O	O
from	from	O	O	O	O
that	that	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
noncyanotic	noncyanotic	O	O	O	O
patients	patients	O	O	O	O
(	(	O	O	O	O
p	p	O	O	OTHERS	I
=	=	O	O	O	O
0.243	0.243	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Although	although	O	O	O	O
clinically	clinically	O	O	O	O
silent	silent	O	O	O	O
,	,	O	O	O	O
CIN	cin	O	O	OTHERS	I
is	is	O	O	O	O
not	not	O	O	O	O
rare	rare	O	O	O	O
in	in	O	O	O	O
pediatrics	pediatrics	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
incidence	incidence	O	O	O	O
depends	depends	O	O	O	O
on	on	O	O	O	O
dosage	dosage	O	O	O	O
but	but	O	O	O	O
not	not	O	O	O	O
on	on	O	O	O	O
the	the	O	O	O	O
type	type	O	O	O	O
of	of	O	O	O	O
consumed	consumed	O	O	O	O
nonionic	nonionic	O	O	O	O
CM	cm	O	DISEASE	OTHERS	I
,	,	O	O	O	O
nor	nor	O	O	O	O
on	on	O	O	O	O
the	the	O	O	O	O
presence	presence	O	O	O	O
of	of	O	O	O	O
cyanosis	cyanosis	O	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
although	although	O	O	O	O
CIN	cin	O	O	OTHERS	I
usually	usually	O	O	O	O
is	is	O	O	O	O
reversible	reversible	O	O	O	O
,	,	O	O	O	O
more	more	O	O	O	O
concern	concern	O	O	O	O
is	is	O	O	O	O
needed	needed	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
prevention	prevention	O	O	O	O
of	of	O	O	O	O
such	such	O	O	O	O
a	a	O	O	O	O
complication	complication	O	O	O	O
in	in	O	O	O	O
children	children	O	O	O	O
.	.	O	O	O	O

